SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SABS

Sab Biotherapeutics Inc.
NASDAQHealth Care

Latest close: 2.53 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Jul 7, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record40622 flagged findings
Reported transactions (Form 4)55since Jun 7, 2022 · and 14 other holdings
Corporate events (8-K)30since Jan 27, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…In December 2022, the Company entered into a securities purchase agreement with certain institutional and accredited investors for…”
    +1 more passage from the same document
    • “…to purchase up to 736,337 shares of common stock, in a private placement offering. The combined purchase price of each share and…”
  • 2026-05-12merger or acquisition eventrecentOpen filing ↗
    “…and the pre-funded warrants on a relative fair value basis and charged to additional paid-in capital. For additional information…”
  • 2026-05-12reverse splitrecentOpen filing ↗
    “…for such warrants), which may be outside the control of the Company. For more information see Note 8, Stockholders’ Equity.…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jan 5, 2024) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 406)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 268-K ↗Current report · Other events new
  • Sep 18, 26Form 4 ↗Insider transaction
  • Aug 21, 26424B3 ↗Securities offering
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Commodore Capital LP · 9.9% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Caligan Partners LP · 8.8% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Vivo Opportunity Fund Holdings, L.P. · 10.0% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 7.3% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · BALYASNY ASSET MANAGEMENT L.P. · 9.4% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Woodline Partners LP · 6.8% · event on Jun 30, 26 · amendment
  • Aug 12, 26SCHEDULE 13G ↗Passive stake · Adage Capital Management, L.P. · 8.4% · event on Jun 30, 26
  • Aug 10, 26SCHEDULE 13D/A ↗Stake with intent to influence · RA Capital Management, L.P. · 9.9% · event on Aug 6, 26 · amendment
  • Aug 6, 2610-Q ↗Quarterly report
  • Jul 7, 268-K ↗Current report · Communication to the market
  • Jun 26, 26Form 4 ↗Insider transaction
  • Jun 18, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G ↗Passive stake · Caligan Partners LP · 10.4% · event on Mar 31, 26
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 8.4% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G ↗Passive stake · Balyasny Asset Management L.P. · 10.0% · event on Mar 31, 26
  • May 12, 2610-Q ↗Quarterly report
  • May 4, 268-K ↗Current report · Entered a material agreement
  • May 1, 26SCHEDULE 13G ↗Passive stake · Millennium Management LLC · 5.1% · event on Apr 24, 26
  • Apr 30, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 22, 268-K ↗Current report · Communication to the market
  • Mar 25, 26Form 4 ↗Insider transaction
  • Mar 23, 26SCHEDULE 13D/A ↗Stake with intent to influence · RA Capital Management, L.P. · 9.9% · event on Mar 19, 26 · amendment

406 filings on record, the oldest from Dec 7, 20.

Listing the 25 most recent filings of the 406 on record.

8-Ks, explained

Stress5Structure28Governance19
  • May 4, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Mar 19, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2025 – 2026show all 3hide
    • Jan 7, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 30, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Sep 26, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 21, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Feb 5, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2024show all 3hide
    • Jul 31, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 31, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 8, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 8, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 2, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 26, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Nov 20, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Nov 14, 23StructureSold unregistered shares+2 more in the same filing8-K/A 3.02 ↗
  • Oct 27, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

7 older filings not shown · The record reaches back to Jan 12, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Mar 31, 23StressPast accounts declared unreliable and being restated+1 more in the same filing8-K 4.02 ↗
  • Jan 27, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 7, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 22, 21StressPast accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗
  • May 21, 21StressPast accounts declared unreliable and being restated8-K 4.02 ↗

The full record holds 5 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • RA Capital Management, L.P.9.9%Aug 6, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Vivo Opportunity Fund Holdings, L.P.10.0%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Commodore Capital LP9.9%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • BALYASNY ASSET MANAGEMENT L.P.9.4%Jun 30, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • BVF PARTNERS L P/IL9.1%Dec 31, 25SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Caligan Partners LP8.8%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 5 more holdershide
  • Adage Capital Management, L.P.8.4%Jun 30, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Perceptive Advisors LLC7.3%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Woodline Partners LP6.8%Jun 30, 26SCHEDULE 13G/A ↗
  • Millennium Management LLC5.1%Apr 24, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • RTW Investments, LP3.2%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 7, 23Buy$2KEddie Joe SullivanChief Executive Officer↗
  • Nov 30, 23Buy$5KMichael KingCHIEF FINANCIAL OFFICER↗
  • Nov 29, 23Buy$10KSamuel J ReichExecutive Chairman↗
Stock compensation, tax and giftsshow the 12 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 17, 26Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Jun 25, 26Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Mar 24, 26Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Dec 11, 25Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Sep 29, 25Compensation$3.0MSessa Capital (Master), L.P.↗
  • Sep 19, 25Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Mar 27, 25Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Dec 18, 24Taxamount n/aAlexandra KropotovaCHIEF MEDICAL OFFICER↗
  • Nov 24, 23Compensationamount n/aSessa Capital (Master), L.P.↗
  • Nov 24, 23Compensationamount n/aHelen K. Ellias↗
  • Mar 14, 23Compensationamount n/aAlexandra KropotovaChief Medical Officer↗
  • Jun 7, 22Giftamount n/aCHRISTINE E HAMILTON↗

The full record holds 15 transactions and goes back to Jun 7, 22.

Its sector and its market

Sab Biotherapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Sab Biotherapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Sab Biotherapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
406 documents on file, from Dec 7, 2020 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.